AI assistant
DEXCOM INC — Director's Dealing 2016
Jan 22, 2016
30198_dirs_2016-01-22_630baa73-b60b-4c3b-b50c-6467210ad369.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2016-01-20
Reporting Person: SAYER KEVIN R (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-01-20 | Common Stock | S | 7000.0 | $75.0 | Disposed | 336402 | Direct |
Footnotes
F1: On December 14, 2015, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2: Included in this number are 190,000 unvested restricted stock units, 90,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018, 75,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017, and 25,000 of which were granted on March 11, 2013 and shall vest through March 11, 2016.